Chattem to buy J&J, Pfizer brands for $410 million
502540
Johnson & Johnson  and Pfizer Inc.  have agreed to sell the U.S. rights to five brands, including anti-diarrhea drug Kaopectate, to Chattem Inc.  for $410 million to satisfy regulatory requirements, Chattem said on Friday.
661105
US health titan Johnson and Johnson has reached a deal to acquire US heart device manufacturer Guidant Corporation, in a stock-and-cash deal valued at $23.9 billion, based on $76 a share, the companies said in a statement early this morning.
456344
Johnson &amp; Johnson  said  on Monday it would buy Pfizer Inc.&#039;s  consumer  health-care business for &#36;16.6 billion in cash to increase its  lead in the market for non-prescription health products.
478171
INDIANAPOLIS - Health care products giant Johnson &amp; Johnson&#39;s $25.4 billion acquisition of Guidant Corp., formally announced Thursday, could face a tough review from regulators because of their competition in the coronary stent market, analysts say.
246083
Johnson &amp; Johnson (JNJ.N: Quote, Profile, Research) will buy Guidant Corp. (GDT.N: Quote, Profile, Research) for $23.9 billion in cash and stock, giving the health-care products
341615
Johnson &amp; Johnson&#39;s$25.4bn purchase of Guidant, a medical device maker, will give the big US medical group a range of fast-growing products that manage patients&#39; heart rhythms, a move that will shake up the US medical device industry.
160352
Health care and consumer products maker Johnson & Johnson is in negotiations to acquire medical-device maker Guidant Corp., sources familiar with the situation said on Tuesday.
721072
Dow Jones & Co. DJ.N, publisher of  The Wall Street Journal, has agreed to buy online financial  news provider MarketWatch Inc. MKTW.O for about $463 million  in a bid to boost its revenue from the fast-growing Internet  advertising market.
169716
Johnson &amp; Johnson (JNJ:NYSE - news - research) said Wednesday night that it would acquire medical equipment maker Guidant (GDT:NYSE - news - research) for $23.9 billion in cash and stock.
72369
Johnson &amp; Johnson (J&amp;J) agreed yesterday to acquire Guidant Corporation for $25.4 billion (R147 billion), adding electrical devices for treating heart disease to
368114
Johnson &amp; Johnson announced last night that will buy medical-device maker Guidant for $23.9 billion in cash and stock. The deal, approved by both boards but subject to regulator approval, is one of the largest
124566
Procter & Gamble Co. PG.N on Friday  said it would buy Gillette Co. G.N in a deal worth about  $55.8 billion, uniting two of the world's largest makers of  household goods ranging from Pampers diapers to Duracell  batteries.
680919
Johnson &amp; Johnson, the maker of Band- Aids and other products, is in talks to buy Guidant Corp. for more than $24 billion, the New York Times reported, citing unidentified executives familiar with the talks.
16804
Johnson &amp; Johnson Chief Executive Officer William Weldon plans to use the $25 billion purchase of defibrillator maker Guidant Corp.
140913
Pfizer Inc. and Johnson &amp; Johnson have agreed to sell off several of their products to settle concerns that J&amp;J's acquisition of Pfizer's consumer health care business would reduce competition, the Federal Trade Commission said Tuesday.
515947
Rite Aid Corp. , the No. 3 U.S.  drugstore chain, on Thursday said it will buy the Brooks and  Eckerd drugstore chains from Canada's Jean Coutu Group (PJC)  Inc. (PJCa.TO) for about $2.6 billion in cash and stock.
607732
Shares of cardiovascular device maker  Guidant Corp. GDT.N jumped 6 percent on Tuesday, following a  report that Johnson & Johnson JNJ.N is in advanced talks to  buy it for more than $24 billion.